InsiderClue
Insiders · Profile

Carver Kyle

Chief Financial Officer at Evommune. Filing since 28 May 2026. CIK 0001757072

Company
Date
Role
Action
Shares
Amount
Of holding
EVMN Evommune, Inc.
8 Jul 2026
Chief Financial Officer
Bought
1,000
$13.26K
1.7%
EVMN Evommune, Inc.
28 May 2026
Chief Financial Officer
Sold on a plan
18,175
$415.12K
23.4%
2 decisions on file.